Mineralys Therapeutics, Inc. ($MLYS)
Rodman David Malcom โ Chief Medical Officer
Shares
2,171
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 12, 2026
EPS:-0.40 (est: -0.52)-22.5%
Transaction Details
| Insider | Rodman David Malcom |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Mar 9, 2026 |
| Expiration Date | Feb 9, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 10, 2026 |
| Shares Purchased | 2,171 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 23,876 |
| Derivative | Derivative |
| Accession Number | 0001672659-26-000015 |
| Document | View SEC Filing |